J IMMUNOTHER CANCER 润色咨询

Journal for ImmunoTherapy of Cancer

出版年份:暂无数据 年文章数:326 投稿命中率:28.0%

出版周期:暂无数据 自引率:5.6% 审稿周期:平均2.58月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均2.58月 (网友贡献,非官方数据)
投稿命中率
28.0% (网友贡献,非官方数据)
审稿费用
2500.0元/篇 (网友贡献,非官方数据)
版面费用
2633.33元/篇 (网友贡献,非官方数据)
中国人发表比例
2019年中国人文章占该期刊总数量21.47% (2018年为6.29%)
自引率
5.6 %
年文章数
326
期刊官网
点击查看 (点击次数:3706)
点击查看 (点击次数:2734次)
作者需知
点击查看 (点击次数:1072次)
期刊简介
稿件收录要求
Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. 
打开APP